Outlook Therapeutics, Inc.
OTLK
$0.39
$0.0410.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.68M | 8.08M | 8.90M | 7.56M | 5.70M |
| Total Receivables | 114.60K | 1.49M | 1.75M | -- | -- |
| Inventory | 3.46M | 3.34M | 4.13M | 3.60M | 3.11M |
| Prepaid Expenses | 4.92M | 4.48M | 6.32M | 6.65M | 6.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.17M | 17.39M | 21.10M | 17.81M | 15.67M |
|
|
|||||
| Total Current Assets | 17.17M | 17.39M | 21.10M | 17.81M | 15.67M |
| Net Property, Plant & Equipment | 212.40K | 225.50K | 238.30K | 250.70K | 262.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 346.10K | 417.50K | 464.40K | 393.80K | 416.00K |
| Total Assets | 18.24M | 18.58M | 22.39M | 19.08M | 17.01M |
|
|
|||||
| Total Accounts Payable | 7.32M | 10.19M | 10.26M | 7.77M | 12.19M |
| Total Accrued Expenses | 4.71M | 5.31M | 5.31M | 3.15M | 3.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 36.72M | 30.01M | 14.06M | 12.05M | 30.80M |
| Total Finance Division Other Current Liabilities | 302.00K | 302.00K | 1.86M | 1.86M | 1.86M |
| Total Other Current Liabilities | 302.00K | 302.00K | 1.86M | 1.86M | 1.86M |
| Total Current Liabilities | 49.06M | 45.81M | 31.49M | 24.82M | 48.24M |
|
|
|||||
| Total Current Liabilities | 49.06M | 45.81M | 31.49M | 24.82M | 48.24M |
| Long-Term Debt | -- | -- | 20.44M | 21.05M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 172.00K | 188.80K | 204.10K | 219.00K | 233.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.56M | 4.77M | 7.45M | 5.45M | 18.83M |
| Total Liabilities | 56.79M | 50.77M | 59.58M | 51.54M | 67.30M |
|
|
|||||
| Common Stock & APIC | 590.22M | 573.52M | 555.23M | 539.80M | 475.62M |
| Retained Earnings | -628.77M | -605.71M | -592.42M | -572.26M | -525.91M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.55M | -32.19M | -37.19M | -32.46M | -50.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.55M | -32.19M | -37.19M | -32.46M | -50.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.55M | -32.19M | -37.19M | -32.46M | -50.29M |
|
|
|||||